STC2 and neoplasm: In some malignant neoplasms, including esophageal squamous cell cancers [13], gastric cancers [11], colorectal cancers [28], and renal cell carcinomas [29], high expression of STC2 correlates with tumor progression and poor prognosis, which is consistent with our findings in LSCC.